Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltoprazine for Levodopa-induced Dyskinesia in Parkinson's Disease
NCT02439125Phase 2Unknown
- Sponsor
- Amarantus BioScience
- Start
- May 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltoprazine in levodopa-induced dyskinesia (LID), sponsored by Amarantus BioScience. Status: unknown.
02
Drugs
eltoprazine
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT02439125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02439125.